INOVIO PHARMACEUTICALS, INC. Cost Method Investments, Fair Value Disclosure
INOVIO PHARMACEUTICALS, INC. (INO) had Cost Method Investments, Fair Value Disclosure of $2.33 million as of 2017-12-31, per its 10-K filed 2018-03-14.
Discontinued › Notes › Investments
us-gaap:CostMethodInvestmentsFairValueDisclosure · last filed 2018-03-14
- 2017-12-31: Cost Method Investments, Fair Value Disclosure $2.33M.
- 2017-09-30: Cost Method Investments, Fair Value Disclosure $2.72M.
- 2017-06-30: Cost Method Investments, Fair Value Disclosure $3.34M.
- 2017-03-31: Cost Method Investments, Fair Value Disclosure $3.03M.
| Period end | Cost Method Investments, Fair Value Disclosure |
|---|---|
| 2017-12-31 | $2.33M 10-K · filed 2018-03-14 |
| 2017-09-30 | $2.72M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $3.34M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $3.03M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $3.78M 10-K · filed 2018-03-14 |
| 2016-09-30 | $4.54M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $5.31M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $5.03M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $5.05M 10-K · filed 2017-03-15 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |